Literature DB >> 23154975

Smad7 inhibits autocrine expression of TGF-β2 in intestinal epithelial cells in baboon necrotizing enterocolitis.

Kopperuncholan Namachivayam1, Cynthia L Blanco, Krishnan MohanKumar, Ramasamy Jagadeeswaran, Margarita Vasquez, Lisa McGill-Vargas, Steven A Garzon, Sunil K Jain, Ravinder K Gill, Nancy E Freitag, Jörn-Hendrik Weitkamp, Steven R Seidner, Akhil Maheshwari.   

Abstract

Preterm infants may be at risk of necrotizing enterocolitis (NEC) due to deficiency of transforming growth factor-β 2 (TGF-β(2)) in the developing intestine. We hypothesized that low epithelial TGF-β(2) expression in preterm intestine and during NEC results from diminished autocrine induction of TGF-β(2) in these cells. Premature baboons delivered at 67% gestation were treated per current norms for human preterm infants. NEC was diagnosed by clinical and radiological findings. Inflammatory cytokines, TGF-β(2), Smad7, Ski, and strawberry notch N (SnoN)/Ski-like oncoprotein (SKIL) was measured using quantitative reverse transcriptase-polymerase chain reaction, immunoblots, and immunohistochemistry. Smad7 effects were examined in transfected IEC6 intestinal epithelial cells in vitro. Findings were validated in archived human tissue samples of NEC. NEC was recorded in seven premature baboons. Consistent with existing human data, premature baboon intestine expressed less TGF-β(2) than term intestine. TGF-β(2) expression was regulated in epithelial cells in an autocrine fashion, which was interrupted in the premature intestine and during NEC due to increased expression of Smad7. LPS increased Smad7 binding to the TGF-β(2) promoter and was associated with dimethylation of the lysine H3K9, a marker of transcriptional silencing, on the nucleosome of TGF-β(2). Increased Smad7 expression in preterm intestine was correlated with the deficiency of SnoN/SKIL, a repressor of the Smad7 promoter. Smad7 inhibits autocrine expression of TGF-β(2) in intestinal epithelial cells in the normal premature intestine and during NEC. Increased Smad7 expression in the developing intestine may be due to a developmental deficiency of the SnoN/SKIL oncoprotein.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23154975      PMCID: PMC3543645          DOI: 10.1152/ajpgi.00141.2012

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  52 in total

1.  Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.

Authors:  Massimo C Fantini; Christoph Becker; Giovanni Monteleone; Francesco Pallone; Peter R Galle; Markus F Neurath
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

2.  Evidence for a role of the JNK cascade in Smad7-mediated apoptosis.

Authors:  A Mazars; F Lallemand; C Prunier; J Marais; N Ferrand; M Pessah; G Cherqui; A Atfi
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

3.  Regulation of intestinal epithelial cell growth by transforming growth factor type beta.

Authors:  J A Barnard; R D Beauchamp; R J Coffey; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

4.  Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.

Authors:  Sofia Edlund; Shizhong Bu; Norbert Schuster; Pontus Aspenström; Rainer Heuchel; Nils-Erik Heldin; Peter ten Dijke; Carl-Henrik Heldin; Maréne Landström
Journal:  Mol Biol Cell       Date:  2003-02       Impact factor: 4.138

5.  Effects of ibuprofen treatment on the developing preterm baboon kidney.

Authors:  Megan R Sutherland; Bradley A Yoder; Donald McCurnin; Steven Seidner; Lina Gubhaju; Ronald I Clyman; M Jane Black
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-22

6.  TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis.

Authors:  B Del Zotto; G Mumolo; A M Pronio; C Montesani; R Tersigni; M Boirivant
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

7.  A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation.

Authors:  Giovanni Monteleone; Jelena Mann; Ivan Monteleone; Piero Vavassori; Ronald Bremner; Massimo Fantini; Giovanna Del Vecchio Blanco; Roberto Tersigni; Luciano Alessandroni; Derek Mann; Francesco Pallone; Thomas T MacDonald
Journal:  J Biol Chem       Date:  2003-11-04       Impact factor: 5.157

8.  Repression of endogenous Smad7 by Ski.

Authors:  Natalia G Denissova; Fang Liu
Journal:  J Biol Chem       Date:  2004-05-05       Impact factor: 5.157

Review 9.  Smad7 in TGF-beta-mediated negative regulation of gut inflammation.

Authors:  Giovanni Monteleone; Francesco Pallone; Thomas T MacDonald
Journal:  Trends Immunol       Date:  2004-10       Impact factor: 16.687

10.  GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor.

Authors:  Weibin Shi; Chuanxi Sun; Bin He; Wencheng Xiong; Xingming Shi; Dachun Yao; Xu Cao
Journal:  J Cell Biol       Date:  2004-01-12       Impact factor: 10.539

View more
  30 in total

1.  Transforming growth factor-β2 is sequestered in preterm human milk by chondroitin sulfate proteoglycans.

Authors:  Kopperuncholan Namachivayam; Hayley P Coffing; Nehru Viji Sankaranarayanan; Yingzi Jin; Krishnan MohanKumar; Brandy L Frost; Cynthia L Blanco; Aloka L Patel; Paula P Meier; Steven A Garzon; Umesh R Desai; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-04       Impact factor: 4.052

2.  Amniotic fluid-borne hepatocyte growth factor protects rat pups against experimental necrotizing enterocolitis.

Authors:  Sunil K Jain; Eric W Baggerman; Krishnan Mohankumar; Kopperuncholan Namachivayam; Ramasamy Jagadeeswaran; Victor E Reyes; Akhil Maheshwari
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-09       Impact factor: 4.052

3.  Targeted inhibition of thrombin attenuates murine neonatal necrotizing enterocolitis.

Authors:  Kopperuncholan Namachivayam; Krishnan MohanKumar; Darla R Shores; Sunil K Jain; Jennifer Fundora; Allen D Everett; Ling He; Hua Pan; Samuel A Wickline; Akhil Maheshwari
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-04       Impact factor: 11.205

Review 4.  The science and necessity of using animal models in the study of necrotizing enterocolitis.

Authors:  Guillermo J Ares; Steven J McElroy; Catherine J Hunter
Journal:  Semin Pediatr Surg       Date:  2017-11-06       Impact factor: 2.754

Review 5.  Necrotizing enterocolitis: new insights into pathogenesis and mechanisms.

Authors:  Diego F Niño; Chhinder P Sodhi; David J Hackam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-08-18       Impact factor: 46.802

6.  Hepatic Insulin Resistance and Altered Gluconeogenic Pathway in Premature Baboons.

Authors:  Lisa McGill-Vargas; Amalia Gastaldelli; Hanyu Liang; Diana Anzueto Guerra; Teresa Johnson-Pais; Steven Seidner; Donald McCurnin; Giovanna Muscogiuri; Ralph DeFronzo; Nicolas Musi; Cynthia Blanco
Journal:  Endocrinology       Date:  2017-05-01       Impact factor: 4.736

Review 7.  Cytokines and growth factors in the developing intestine and during necrotizing enterocolitis.

Authors:  Krishnan MohanKumar; Kopperuncholan Namachivayam; Thao T B Ho; Benjamin A Torres; Robin K Ohls; Akhil Maheshwari
Journal:  Semin Perinatol       Date:  2016-11-07       Impact factor: 3.300

Review 8.  Innate and adaptive immunity in necrotizing enterocolitis.

Authors:  Madison A Mara; Misty Good; Joern-Hendrik Weitkamp
Journal:  Semin Fetal Neonatal Med       Date:  2018-08-17       Impact factor: 3.926

Review 9.  Immunologic and Hematological Abnormalities in Necrotizing Enterocolitis.

Authors:  Akhil Maheshwari
Journal:  Clin Perinatol       Date:  2015-05-13       Impact factor: 3.430

10.  TGF-β2, a protective intestinal cytokine, is abundant in maternal human milk and human-derived fortifiers but not in donor human milk.

Authors:  Aaron A Reeves; Marney C Johnson; Margarita M Vasquez; Akhil Maheshwari; Cynthia L Blanco
Journal:  Breastfeed Med       Date:  2013-07-19       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.